Pan-immune-inflammation value is associated with all-cause and cause-specific mortality among individuals with cancer survivors: a population-based longitudinal cohort study
Elevated PIV independently predicts higher all-cause and cancer-specific mortality in cancer survivors. The findings suggest that PIV may serve as a practical prognostic marker, with renal function partially accounting for its link to mortality.
Authors
- Juhua Dai
- Xinping Sun
- Bei Lin (ORCID: https://orcid.org/0000-0002-8881-9859)
- Liyuan Chen (ORCID: https://orcid.org/0000-0002-1088-4386)
- Yujing Sun (ORCID: https://orcid.org/0000-0002-8077-8060)
Institutions
- Peking University (CN)
- Peking University International Hospital (CN)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1016/j.ctarc.2025.101070
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00